Steven Cohen Keros Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$39.3 Billion
Q1 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 971,881 shares of KROS stock, worth $44.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

971,881

Previous 81,230 1096.46%

Holding current value

$44.4 Million

Previous $3.23 Million 1892.51%

% of portfolio

0.16%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$41.26 - $70.48 $36.7 Million - $62.8 Million	890,651 Added 1096.46%	971,881 $64.3 Million
Q4 2023 Feb 14, 2024	SELL	$27.12 - $41.05 $1.86 Million - $2.81 Million	-68,503 Reduced 45.75%	81,230 $3.23 Million
Q3 2023 Nov 14, 2023	SELL	$31.57 - $43.02 $6.31 Million - $8.6 Million	-199,927 Reduced 57.18%	149,733 $4.77 Million
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $5.37 Million - $7.35 Million	144,000 Added 70.02%	349,660 $14 Million
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $13 Million - $18.7 Million	-314,876 Reduced 60.49%	205,660 $8.78 Million

Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $16.9 Million - $22.2 Million	428,696 Added 466.79%	520,536 $25 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $2.55 Million - $3.68 Million	91,840 New	91,840 $3.46 Million
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $2.65 Million - $3.74 Million	-63,028 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $3.16 Million - $5.38 Million	-85,572 Reduced 57.59%	63,028 $3.69 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $7.43 Million - $11.1 Million	-254,007 Reduced 63.09%	148,600 $5.88 Million
Q2 2021 Aug 16, 2021	BUY	$42.4 - $70.11 $7.61 Million - $12.6 Million	179,445 Added 80.41%	402,607 $17.1 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $505,548 - $704,771	9,362 Added 4.38%	223,162 $13.7 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $4.79 Million - $11 Million	133,000 Added 164.6%	213,800 $15.1 Million
Q3 2020 Nov 16, 2020	SELL	$27.04 - $62.21 $1.93 Million - $4.45 Million	-71,500 Reduced 46.95%	80,800 $3.12 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $3.06 Million - $6.15 Million	152,300 New	152,300 $5.71 Million

Others Institutions Holding KROS

# of Institutions

153

Shares Held

26.7M

Call Options Held

47.6K

Put Options Held

34.5K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account